Article
Epithelial-mesenchymal transition and H<sub>2</sub>O<sub>2</sub> signaling – a driver of disease progression and a vulnerability in cancers
15 Jan 2022
Abstract excerpt
Abstract Mutation-selective drugs constitute a great advancement in personalized anticancer treatment with increased quality of life and overall survival in cancers. However, the high adaptability and evasiveness of cancers can lead to disease progression and the development of drug resistance, which cause recurrence and metastasis. A common characteristic in advanced neoplastic cancers is the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
